Accelerating Therapeutic DiscoveryTM

News From The Alpha-1 Project

20
- Alnylam Remains On Track to File Investigational New Drug (IND) Application in Mid 2015 -Cambridge, Mass., and Miami, Fla., June 19, 2014 – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and The Alpha-1 Project (...

[Read More...]

10
The Alpha-1 Project, the venture philanthropy arm of the Alpha-1 Foundation, today announced it will fund a two-year postdoctoral fellowship position at the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (N...

[Read More...]

13
CORAL GABLES, FL (January 13, 2014) – The Alpha-1 Project, a venture philanthropy company created to speed development of new therapies and potential cures for lung and liver diseases caused by Alpha-1 Antitrypsin Deficiency, announced a partne...

[Read More...]

10
MIAMI, FL and WORCESTER, MA (Jan. 8, 2014) – The Alpha-1 Project (TAP) today announced a commission to the University of Massachusetts Medical School (UMMS) to develop a PiZ antibody. The antibody will be used to track the presence of mutant al...

[Read More...]

01
SAN DIEGO, August XX, 2013—Carolus Therapeutics, Inc. and The Alpha-1 Project, Inc. (TAP), a wholly-owned subsidiary of the Alpha-1 Foundation, today announced that they are collaborating  to characterize human biological samples for the p...

[Read More...]

Page 3 of 4First   Previous   1  2  [3]  4  Next   Last